Laurus Labs Limited
LAURUSLABS
Rankning i aktier
#1747
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Aktiekurs
$22.83
Senast synkroniserad: 2026-10-19
Marknadsvärde
$12.34B
Förändring (1 dag)
0.51%
Förändring (1 år)
117.95%
Land
IN
Handel Laurus Labs Limited (LAURUSLABS)
Kategori
Healthcare
Vinst för Laurus Labs Limited (LAURUSLABS)
Vinst i Jun 2026 TTM: $158.77M
Enligt de senaste finansiella rapporterna från Laurus Labs Limited är företagets nuvarande vinst $158.77M. År 2024 hade företaget en vinst på $27.63M, en minskning jämfört med vinsten år 2023 som var $134.55M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Laurus Labs Limited från 2013 till 2026
Vinst vid slutet av varje år
| År | Vinst | Ändra |
|---|---|---|
| 2026 (TTM) | $158.77M | 178.14% |
| 2025 | $57.08M | 106.57% |
| 2024 | $27.63M | -79.46% |
| 2023 | $134.55M | -5.75% |
| 2022 | $142.76M | -19.68% |
| 2021 | $177.74M | 356.04% |
| 2020 | $38.97M | 126.00% |
| 2019 | $17.25M | -52.71% |
| 2018 | $36.46M | 0.99% |
| 2017 | $36.11M | 41.84% |
| 2016 | $25.45M | 137.71% |
| 2015 | $10.71M | -3.94% |
| 2014 | $11.15M | -29.65% |
| 2013 | $15.85M | 0.00% |
Vinst för liknande företag eller konkurrenter
| Företag | Vinst | Skillnad i vinst | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 1,011.36% |
IN
|
